Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

US Patent 10899765 · Granted Jan 26, 2021

Estimated economic value: $45,304,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Modulators of RAS GTPase2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidat2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors2025
Heteroaryl modulators of RAS GTPase2024
Substituted tetrahydropyrans as CCR2 modulators2024
Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors2024
Preparation method of resveratrol nervonic acid ester2024
Pyrazine compounds as inhibitors of FLT32024